{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T08:22:57Z","timestamp":1794644577008,"version":"4.9.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"crossref","award":["67264"],"award-info":[{"award-number":["67264"]}],"id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Polycystic ovary syndrome (PCOS) is one of the most important contributing factors to infertility. In this study, we report the burden of PCOS by age and sociodemographic index (SDI) for the 21 countries in the Middle East and North Africa (MENA) region. Publicly available data on the point prevalence, incidence and years lived with disability (YLDs), from 1990 to 2019, were retrieved from the Global Burden of Disease (GBD) 2019 study for the 21 countries in MENA. The results are presented with age-standardised numbers and rates per 100,000 population, along with their corresponding 95% uncertainty intervals (UIs). In 2019, the age-standardised point prevalence and incidence rate for PCOS in the MENA region were 2079.7 (95% UI: 1392.0 to 2812.3) and 77.2 (95% UI: 51.6 to 105.4) per 100,000, respectively, which represents a 37.9% (95% UI: 31.7 to 45.0) and a 33.7% (95% UI: 27.7 to 40.3) increase since 1990, respectively. Also in 2019, the age-standardised YLD rate of PCOS in this region was 18.7 (95% UI: 7.8 to 37.9) per 100,000 women, which has increased by 36.1% (95% UI: 29.4 to 43.4) since 1990. Kuwait [25.4 (10.7, 51.2)] had the highest age-standardised YLD rate, while Afghanistan [10.8 (10.1, 49.2)] had the lowest. Moreover, the largest increase in the YLD rate, from 1990 to 2019, was seen in Sudan [90.3% (64.1, 120.9)], whereas no country decreased during the measurement period. The total prevalent number and point prevalence of PCOS (per 100,000) were both highest in the 20\u201324 age group. The prevalence of PCOS was highest among women of reproductive age, but decreased rapidly after 45\u00a0years of age. Moreover, at the country level there was a positive association between SDI and the age-standardised YLD rates of PCOS. The growing prevalence and burden of PCOS in the MENA region highlights the need to implement cost-effective preventive programs, especially for women in their third decade of life, and in MENA countries with higher SDI levels.<\/jats:p>","DOI":"10.1038\/s41598-022-11006-0","type":"journal-article","created":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T08:04:01Z","timestamp":1651219441000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["Burden of polycystic ovary syndrome in the Middle East and North Africa region, 1990\u20132019"],"prefix":"10.1038","volume":"12","author":[{"given":"Kimia","family":"Motlagh Asghari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Aria","family":"Nejadghaderi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahasti","family":"Alizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarvin","family":"Sanaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J. M.","family":"Sullman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali-Asghar","family":"Kolahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodie","family":"Avery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeid","family":"Safiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,29]]},"reference":[{"issue":"1","key":"11006_CR1","first-page":"17","volume":"18","author":"M Bani Mohammad","year":"2017","unstructured":"Bani Mohammad, M. & Majdi, S. A. Polycystic ovary syndrome (PCOS), diagnostic criteria, and AMH. Asian Pac. J. Cancer Prev. 18(1), 17\u201321 (2017).","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"9588","key":"11006_CR2","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0140-6736(07)61345-2","volume":"370","author":"RJ Norman","year":"2007","unstructured":"Norman, R. J., Dewailly, D., Legro, R. S. & Hickey, T. E. Polycystic ovary syndrome. Lancet 370(9588), 685\u2013697 (2007).","journal-title":"Lancet"},{"issue":"1","key":"11006_CR3","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/j.1365-2605.2005.00623.x","volume":"29","author":"S Franks","year":"2006","unstructured":"Franks, S., McCarthy, M. I. & Hardy, K. Development of polycystic ovary syndrome: involvement of genetic and environmental factors. Int. J. Androl. 29(1), 278\u2013285 (2006).","journal-title":"Int. J. Androl."},{"issue":"6","key":"11006_CR4","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1210\/jc.2003-032046","volume":"89","author":"R Azziz","year":"2004","unstructured":"Azziz, R. et al. The prevalence and features of the polycystic ovary syndrome in an unselected population. J. Clin. Endocrinol. Metab. 89(6), 2745\u20132749 (2004).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"11006_CR5","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1093\/humrep\/dew218","volume":"31","author":"G Bozdag","year":"2016","unstructured":"Bozdag, G., Mumusoglu, S., Zengin, D., Karabulut, E. & Yildiz, B. O. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum. Reprod. 31(12), 2841\u20132855 (2016).","journal-title":"Hum. Reprod."},{"issue":"8","key":"11006_CR6","doi-asserted-by":"publisher","first-page":"4650","DOI":"10.1210\/jc.2005-0628","volume":"90","author":"R Azziz","year":"2005","unstructured":"Azziz, R., Marin, C., Hoq, L., Badamgarav, E. & Song, P. Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span. J. Clin. Endocrinol. Metab. 90(8), 4650\u20134658 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"11006_CR7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ejogrb.2007.12.018","volume":"139","author":"X Chen","year":"2008","unstructured":"Chen, X. et al. Prevalence of polycystic ovary syndrome in unselected women from southern China. Eur. J. Obstet. Gynecol. Reprod. Biol. 139(1), 59\u201364 (2008).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"5","key":"11006_CR8","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1089\/met.2010.0039","volume":"8","author":"AA Bremer","year":"2010","unstructured":"Bremer, A. A. Polycystic ovary syndrome in the pediatric population. Metab. Syndr. Relat. Disord. 8(5), 375\u2013394 (2010).","journal-title":"Metab. Syndr. Relat. Disord."},{"issue":"4","key":"11006_CR9","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1093\/humrep\/deaa371","volume":"36","author":"J Liu","year":"2021","unstructured":"Liu, J. et al. Measuring the global disease burden of polycystic ovary syndrome in 194 countries: Global Burden of Disease Study 2017. Hum Reprod. 36(4), 1108\u20131119 (2021).","journal-title":"Hum Reprod."},{"issue":"4","key":"11006_CR10","doi-asserted-by":"publisher","first-page":"333","DOI":"10.4103\/ijmr.IJMR_1937_17","volume":"150","author":"MA Ganie","year":"2019","unstructured":"Ganie, M. A. et al. Epidemiology, pathogenesis, genetics & management of polycystic ovary syndrome in India. Indian J. Med. Res. 150(4), 333\u2013344 (2019).","journal-title":"Indian J. Med. Res."},{"issue":"2","key":"11006_CR11","doi-asserted-by":"publisher","first-page":"343","DOI":"10.5114\/aoms.2019.87112","volume":"17","author":"T Miazgowski","year":"2019","unstructured":"Miazgowski, T., Martopullo, I., Widecka, J., Miazgowski, B. & Brodowska, A. National and regional trends in the prevalence of polycystic ovary syndrome since 1990 within Europe: the modeled estimates from the Global Burden of Disease Study 2016. Arch. Med. Sci. AMS. 17(2), 343\u2013351 (2019).","journal-title":"Arch. Med. Sci. AMS."},{"key":"11006_CR12","doi-asserted-by":"publisher","first-page":"S631","DOI":"10.1016\/j.jval.2019.09.1201","volume":"22","author":"P Rajora","year":"2019","unstructured":"Rajora, P., Goli, N., Savner, R., Singh, A. & Bhutani, M. K. PIH20 A targeted literature review of the economic burden associated with polycystic ovary syndrome. Value in Health. 22, S631 (2019).","journal-title":"Value in Health."},{"issue":"10258","key":"11006_CR13","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"T Vos","year":"2020","unstructured":"Vos, T. et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 396(10258), 1204\u20131222 (2020).","journal-title":"Lancet"},{"issue":"10258","key":"11006_CR14","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","volume":"396","author":"CJL Murray","year":"2020","unstructured":"Murray, C. J. L. et al. Global burden of 87 risk factors in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 396(10258), 1223\u20131249 (2020).","journal-title":"Lancet"},{"key":"11006_CR15","unstructured":"Wang Y. Smoothing splines: methods and applications: Chapman and Hall\/CRC; 2019."},{"key":"11006_CR16","doi-asserted-by":"crossref","unstructured":"Obstetricians ACo, Gynecologists. Polycystic ovary syndrome. ACOG practice bulletin no. 194. Obstet Gynecol. 11, 131 (2018)","DOI":"10.1097\/AOG.0000000000002656"},{"issue":"3","key":"11006_CR17","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1210\/jc.2005-2501","volume":"91","author":"S Franks","year":"2006","unstructured":"Franks, S. Diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria. J. Clin. Endocrinol. Metab. 91(3), 786\u2013789 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"11006_CR18","doi-asserted-by":"crossref","unstructured":"eshre TR, Group A-SPCW. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil. Steril. 81(1), 19\u201325 (2004)","DOI":"10.1016\/j.fertnstert.2003.10.004"},{"issue":"2","key":"11006_CR19","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","volume":"91","author":"R Azziz","year":"2009","unstructured":"Azziz, R. et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil. Steril. 91(2), 456\u2013488 (2009).","journal-title":"Fertil. Steril."},{"issue":"11","key":"11006_CR20","doi-asserted-by":"publisher","first-page":"e712","DOI":"10.1016\/S2214-109X(15)00069-8","volume":"3","author":"JA Salomon","year":"2015","unstructured":"Salomon, J. A. et al. Disability weights for the Global Burden of Disease 2013 study. Lancet Glob. Health. 3(11), e712\u2013e723 (2015).","journal-title":"Lancet Glob. Health."},{"issue":"10159","key":"11006_CR21","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1016\/S0140-6736(18)32335-3","volume":"392","author":"HH Kyu","year":"2018","unstructured":"Kyu, H. H. et al. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392(10159), 1859\u20131922 (2018).","journal-title":"Lancet"},{"key":"11006_CR22","doi-asserted-by":"crossref","unstructured":"Wang Y. Smoothing splines: methods and applications: Chapman and Hall\/CRC; 2011.","DOI":"10.1201\/b10954"},{"key":"11006_CR23","doi-asserted-by":"crossref","unstructured":"group TREAsPcw. Revised 2003 consensus on diagnostic criteria and long\u2010term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction. 19(1), 41\u20137 (2004)","DOI":"10.1093\/humrep\/deh098"},{"issue":"2","key":"11006_CR24","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1093\/humrep\/dep399","volume":"25","author":"WA March","year":"2010","unstructured":"March, W. A. et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum. Reprod. 25(2), 544\u2013551 (2010).","journal-title":"Hum. Reprod."},{"issue":"11","key":"11006_CR25","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.3390\/ijerph15112589","volume":"15","author":"WM Wolf","year":"2018","unstructured":"Wolf, W. M., Wattick, R. A., Kinkade, O. N. & Olfert, M. D. Geographical prevalence of polycystic ovary syndrome as determined by region and race\/ethnicity. Int. J. Environ. Res. Public Health. 15(11), 2589 (2018).","journal-title":"Int. J. Environ. Res. Public Health."},{"key":"11006_CR26","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2147\/TACG.S200341","volume":"12","author":"MJ Khan","year":"2019","unstructured":"Khan, M. J., Ullah, A. & Basit, S. Genetic basis of polycystic ovary syndrome (PCOS): current perspectives. Appl. Clin Genet. 12, 249\u2013260 (2019).","journal-title":"Appl. Clin Genet."},{"issue":"1","key":"11006_CR27","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12992-020-00585-0","volume":"16","author":"H Naal","year":"2020","unstructured":"Naal, H., El Koussa, M., El Hamouch, M., Hneiny, L. & Saleh, S. A systematic review of global health capacity building initiatives in low-to middle-income countries in the Middle East and North Africa region. Glob. Health 16(1), 56 (2020).","journal-title":"Glob. Health"},{"issue":"7","key":"11006_CR28","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4103\/1119-3077.170820","volume":"18","author":"S Chima","year":"2015","unstructured":"Chima, S. & Mamdoo, F. Ethical and legal dilemmas around termination of pregnancy for severe fetal anomalies: a review of two African neonates presenting with ventriculomegaly and holoprosencephaly. Niger. J. Clin. Pract. 18(7), 31 (2015).","journal-title":"Niger. J. Clin. Pract."},{"issue":"8","key":"11006_CR29","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1111\/imj.12495","volume":"44","author":"S Shorakae","year":"2014","unstructured":"Shorakae, S., Boyle, J. & Teede, H. Polycystic ovary syndrome: a common hormonal condition with major metabolic sequelae that physicians should know about. Intern. Med. J. 44(8), 720\u2013726 (2014).","journal-title":"Intern. Med. J."},{"issue":"1","key":"11006_CR30","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1210\/jc.2007-1834","volume":"93","author":"BO Yildiz","year":"2008","unstructured":"Yildiz, B. O., Knochenhauer, E. S. & Azziz, R. Impact of obesity on the risk for polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 93(1), 162\u2013168 (2008).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"11006_CR31","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12992-019-0457-y","volume":"15","author":"A Fox","year":"2019","unstructured":"Fox, A., Feng, W. & Asal, V. What is driving global obesity trends? Globalization or \u201cmodernization\u201d?. Glob. Health 15(1), 32 (2019).","journal-title":"Glob. Health"},{"issue":"3","key":"11006_CR32","doi-asserted-by":"publisher","first-page":"887s","DOI":"10.1093\/jn\/131.3.887S","volume":"131","author":"N Mokhtar","year":"2001","unstructured":"Mokhtar, N. et al. Diet culture and obesity in northern Africa. J Nutr. 131(3), 887s-s892 (2001).","journal-title":"J Nutr."},{"key":"11006_CR33","doi-asserted-by":"crossref","unstructured":"Anderson, A. D., Solorzano, C. M. B., McCartney, C. R., editors. Childhood obesity and its impact on the development of adolescent PCOS. Seminars in reproductive medicine; 2014: Thieme Medical Publishers.","DOI":"10.1055\/s-0034-1371092"},{"issue":"4","key":"11006_CR34","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1097\/MOP.0000000000000778","volume":"31","author":"SF Witchel","year":"2019","unstructured":"Witchel, S. F., Burghard, A. C., Tao, R. H. & Oberfield, S. E. The diagnosis and treatment of PCOS in adolescents: an update. Curr. Opin. Pediatr. 31(4), 562\u2013569 (2019).","journal-title":"Curr. Opin. Pediatr."},{"issue":"12","key":"11006_CR35","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.1210\/jc.2013-2350","volume":"98","author":"RS Legro","year":"2013","unstructured":"Legro, R. S. et al. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 98(12), 4565\u20134592 (2013).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"11006_CR36","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ando.2017.04.024","volume":"78","author":"P Fenichel","year":"2017","unstructured":"Fenichel, P., Rougier, C., Hieronimus, S. & Chevalier, N. Which origin for polycystic ovaries syndrome: Genetic, environmental or both?. Ann. Endocrinol. 78(3), 176\u2013185 (2017).","journal-title":"Ann. Endocrinol."},{"issue":"3","key":"11006_CR37","doi-asserted-by":"publisher","first-page":"e1071","DOI":"10.1210\/clinem\/dgaa839","volume":"106","author":"KM Hoeger","year":"2021","unstructured":"Hoeger, K. M., Dokras, A. & Piltonen, T. Update on PCOS: consequences, challenges, and guiding treatment. J. Clin. Endocrinol. Metab. 106(3), e1071\u2013e1083 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"11006_CR38","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12916-020-01697-5","volume":"18","author":"I Kyrou","year":"2020","unstructured":"Kyrou, I. et al. Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic. BMC Med. 18(1), 220 (2020).","journal-title":"BMC Med."},{"issue":"5","key":"11006_CR39","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1530\/EJE-20-1163","volume":"184","author":"A Subramanian","year":"2021","unstructured":"Subramanian, A. et al. Increased COVID-19 infections in women with polycystic ovary syndrome: a population-based study. Eur. J. Endocrinol. 184(5), 637\u2013645 (2021).","journal-title":"Eur. J. Endocrinol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-11006-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-11006-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-11006-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T21:26:56Z","timestamp":1669325216000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-11006-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,29]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["11006"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-11006-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,29]]},"assertion":[{"value":"11 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7039"}}